儿童睡眠呼吸障碍中鼻甲成形术联合腺样体扁桃体切除术的成本效益与效用决策分析
该成本-效用决策分析模型基于已发表数据与2018年Centers for Medicare and Medicaid数据库,评估在腺样体扁桃体切除术(T/A)基础上加做双侧下鼻甲成形术治疗儿童阻塞性睡眠呼吸障碍(oSDB)的效用与成本。基线模型显示,在存在鼻甲肥大的假设下,加做鼻甲成形术的总体效用为0.8890,优于单纯T/A的0.8875;增量成本效果比为27,333美元/QALY。敏感性分析表明,鼻甲成形术带来的治疗成功率提高3%是决策阈值。
要点
- 在鼻甲肥大患儿中,T/A加做鼻甲成形术的总体效用为0.8890,优于单纯T/A的0.8875。
- 鼻甲成形术带来的治疗成功率提高3%是加做手术优于单纯T/A的阈值。
- 基线模型增量成本效果比为27,333美元/QALY,低于工业化国家50,000至100,000美元/QALY的支付意愿阈值。
核心结论
- 对于存在鼻甲肥大的儿童oSDB患者,在T/A基础上加做鼻甲成形术从效用和成本效益分析角度看均有益,即使鼻甲成形术的获益相对有限。
研究设计与样本
- 成本-效用决策分析模型,基于假设队列,使用TreeAge软件构建,模型纳入术后并发症和术后持续oSDB的可能性。
- 基线临床与质量调整生命年(QALY)参数采用已发表数据估计,成本数据来自2018年Centers for Medicare and Medicaid数据库。
主要发现
- 基线模型效用分析在假设存在鼻甲肥大的条件下支持加做鼻甲成形术,总体效用为0.8890 vs 0.8875。
- 敏感性分析显示,同期鼻甲成形术带来的治疗成功率提高(%)是模型中的关键参数。
- 鼻甲成形术治疗成功率提高3%是加做鼻甲成形术优于单纯T/A的阈值。
- 基线模型增量成本效果比(ICER)为27,333美元/QALY,优于工业化国家50,000至100,000美元/QALY的支付意愿阈值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Use decision analysis techniques to assess the potential utility gains/losses and costs of adding bilateral inferior turbinoplasty to tonsillectomy/adenoidectomy (T/A) for the treatment of obstructive sleep-disordered breathing (oSDB) in children. Use sensitivity analysis to explore the key variables in the scenario. STUDY DESIGN: Cost-utility decision analysis model. SETTING: Hypothetical cohort. SUBJECTS AND METHODS: Computer software (TreeAge Software, Williamstown, Massachusetts) was used to construct a decision analysis model. The model included the possibility of postoperative complications and persistent oSDB after surgery. Baseline clinical and quality-adjusted life year (QALY) parameters were estimated using published data. Cost data were estimated from Centers for Medicare and Medicaid 2018 databases ( www.cms.gov ). Sensitivity analyses were completed to assess for key model parameters. RESULTS: The utility analysis of the baseline model favored the addition of turbinoplasty (0.8890 vs 0.8875 overall utility) assuming turbinate hypertrophy was present. Sensitivity analysis indicated the treatment success increase (%) provided by concurrent turbinoplasty was the key parameter in the model. A treatment success increase of 3% of turbinoplasty was the threshold where concurrent turbinoplasty was favored over T/A alone. The incremental cost-effectiveness ratio (ICER) of $27,333/QALY for the baseline model was favorable to the willingness-to-pay threshold of $50,000 to $100,000/QALY for industrialized nations. CONCLUSIONS: The addition of turbinoplasty for children with turbinate hypertrophy to T/A for the treatment of pediatric oSDB is beneficial from both a utility and cost-benefit analysis standpoint even if the benefits of turbinoplasty are relatively modest.
引用
- Baik G, Brietzke SE. Cost Benefit and Utility Decision Analysis of Turbinoplasty with Adenotonsillectomy for Pediatric Sleep-Disordered Breathing. Otolaryngol Head Neck Surg. 2019. PMID: 31010383. doi:10.1177/0194599819841882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。